Bachem Holding AG Stock OTC Markets

Equities

BCHMY

US05636G1058

Biotechnology & Medical Research

Market Closed - OTC Markets 10:44:37 2024-07-10 am EDT 5-day change 1st Jan Change
9.585 USD -3.15% Intraday chart for Bachem Holding AG +6.50% +27.80%
Sales 2024 * 620M 693M Sales 2025 * 805M 900M Capitalization 6.56B 7.33B
Net income 2024 * 117M 131M Net income 2025 * 159M 178M EV / Sales 2024 * 10.4 x
Net cash position 2024 * 79.17M 88.47M Net Debt 2025 * 72.87M 81.43M EV / Sales 2025 * 8.23 x
P/E ratio 2024 *
57 x
P/E ratio 2025 *
41.6 x
Employees 2,006
Yield 2024 *
0.99%
Yield 2025 *
1.07%
Free-Float 94.31%
More Fundamentals * Assessed data
Dynamic Chart
1 day-3.15%
1 week+6.50%
Current month+6.50%
1 month+8.92%
3 months+0.89%
6 months+42.21%
Current year+27.80%
More quotes
1 week
9.59
Extreme 9.585
9.90
1 month
9.00
Extreme 9
9.90
Current year
5.94
Extreme 5.94
10.05
1 year
5.94
Extreme 5.94
10.05
3 years
5.94
Extreme 5.94
10.61
5 years
5.94
Extreme 5.94
10.61
10 years
5.94
Extreme 5.94
10.61
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 18-12-31
Director of Finance/CFO 47 21-01-31
Chief Tech/Sci/R&D Officer - 02-12-31
Members of the board TitleAgeSince
Director/Board Member 82 -
Chairman 68 12-04-24
Director/Board Member 51 11-04-12
More insiders
Date Price Change Volume
24-07-10 9.585 -3.15% 500

Delayed Quote OTC Markets, July 10, 2024 at 10:44 am EDT

More quotes
Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
87.45 CHF
Average target price
75.67 CHF
Spread / Average Target
-13.47%
Consensus